RYLDX
Price
$229.37
Change
+$2.30 (+1.01%)
Updated
Jul 31 closing price
Net Assets
43.17M
RYVYX
Price
$787.41
Change
+$9.25 (+1.19%)
Updated
Jul 31 closing price
Net Assets
1.59B
Interact to see
Advertisement

RYLDX vs RYVYX

RYLDX vs RYVYX Comparison Chart in %
View a ticker or compare two or three
VS
RYLDX vs. RYVYX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLDX is a Buy and RYVYX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.59B vs. RYLDX (43.2M). RYLDX pays higher dividends than RYVYX: RYLDX (0.54) vs RYVYX (0.00). RYLDX was incepted earlier than RYVYX: RYLDX (22 years) vs RYVYX (26 years). RYLDX (1.87) and RYVYX (1.87) have similar cost to investors . RYLDX is a more actively managed with annual turnover of: 1015.00 vs. RYVYX (383.00). RYLDX (2500) and RYVYX (2500) have matching initial minimum investment requirements. RYLDX annual gain was more profitable for investors over the last year : 33.47 vs. RYVYX (26.31). RYVYX return over 5 years is better than : 81.53 vs. RYLDX (62.04).
RYLDXRYVYXRYLDX / RYVYX
Total Expense Ratio1.771.74102%
Annual Report Gross Expense Ratio1.871.87100%
Fund Existence22 years26 years-
Gain YTD15.70918.43185%
Front Load5%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets43.2M1.59B3%
Annual Yield % from dividends0.540.00-
Returns for 1 year33.4726.31127%
Returns for 3 years77.12112.9268%
Returns for 5 years62.0481.5376%
Returns for 10 years363.12882.5241%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAICX10.630.05
+0.49%
BlackRock Multi-Asset Income Investor A
TNBIX21.470.04
+0.20%
1290 SmartBeta Equity I
DRRIX17.740.02
+0.11%
BNY Mellon Global Real Return - I
PARMX40.93-0.04
-0.10%
Parnassus Mid-Cap
LYFCX17.38-0.49
-2.74%
AlphaCentric Life Sciences & Hlthcare C